Skip to content
10-K

Annual Report

ACCUSTEM SCIENCES, INC. ACUT

0001493152-24-010938

← back to feed
Filed
Mar 22, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 22, 2024 11.35M sh
Shares Diluted FY 2023 · Dec 31, 2022 11.02M sh
Capex FY 2023 · Dec 31, 2022 $11K
Operating Cash Flow FY 2023 · Dec 31, 2022 −$1.81M
Current Liabilities FY 2023 · Dec 31, 2022 $1.08M
Total Liabilities FY 2023 · Dec 31, 2022 $1.08M
Current Assets FY 2023 · Dec 31, 2022 $932.01K
Total Assets FY 2023 · Dec 31, 2022 $939.69K
Eps Diluted FY 2023 · Dec 31, 2022 −$0.34
Eps Basic FY 2023 · Dec 31, 2022 −$0.34
Sga Expense FY 2023 · Dec 31, 2022 $3.48M
Rd Expense FY 2023 · Dec 31, 2022 $266.93K
Net Income FY 2023 · Dec 31, 2022 −$3.75M
Operating Income FY 2023 · Dec 31, 2022 −$3.75M
Stockholders Equity FY 2023 · Dec 31, 2021 $650.67K